All Stories

  1. RX-3117 (fluorocyclopentenyl cytosine): a novel specific antimetabolite for selective cancer treatment

    Article • Expert Opinion on Investigational Drugs, March 2019, Taylor & Francis

    Elisa Giovannetti, Professor Godefridus J Peters

  2. The microbiome of pancreatic cancer: from molecular diagnostics to new therapeutic approaches to overcome chemoresistance caused by metabolic inactivation of gemcitabine

    Article • Expert Review of Molecular Diagnostics, November 2018, Taylor & Francis

    Elisa Giovannetti, Arthur Tien Fung Choy

  3. miRNA profiling for diagnosis, prognosis and stratification of cancer treatment in cholangiocarcinoma

    Article • Pharmacogenomics, August 2017, Future Medicine

    Elisa Giovannetti

  4. New developments in the management of non-small-cell lung cancer, focus on rociletinib: what went wrong?

    Article • OncoTargets and Therapy, October 2016, Dove Medical Press

    Professor Godefridus J Peters, Elisa Giovannetti

  5. Impact of microRNAs in Resistance to Chemotherapy and Novel Targeted Agents in Non-Small Cell Lung Cancer

    Article • Current Pharmaceutical Biotechnology, August 2014, Bentham Science Publishers

    Elisa Giovannetti

  6. MET As a Potential Target for the Treatment of Upper Gastrointestinal Cancers: Characterization of Novel c-Met Inhibitors from Bench to Bedside

    Article • Current Medicinal Chemistry, February 2014, Bentham Science Publishers

    Elisa Giovannetti